Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 85%
filed 2026-07-06
Item 2.02
This Item 2.02 disclosure provides preliminary financial results for Q2 2026, specifically flagging an expected acquired IPR&D charge of approximately $127 million that will negatively impact both GAAP and non-GAAP net income per diluted share by approximately $1.00. While the full earnings release is not attached, the disclosure of preliminary quarterly financial results and their expected impact on per-share metrics is characteristic of an earnings-related disclosure under Item 2.02, even though the company notes results have not been finalized.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 2.02
This Item 2.02 disclosure presents preliminary unaudited estimates of Rivian's Q2 2026 financial results, including total consolidated revenues (estimated $1.55–$1.65 billion, up from $1.30 billion in Q2 2025) and cash position ($5.3 billion as of June 30, 2026). The disclosure explicitly states these are "preliminary estimates of selected financial information" and explains the drivers of revenue growth (increased vehicle deliveries, higher commercial van mix, software services, and regulatory credits). This is a classic earnings release format—preliminary financial results disclosed via 8-K Item 2.02 ahead of full quarterly filings—and is material to investors assessing the company's operational performance and financial trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 2.02
This is a straightforward earnings release disclosing Q1 2026 financial results for Exyn Technologies. The filing explicitly states "On July 6, 2026, Exyn Technologies, Inc. issued a press release announcing its financial results for the three months ended March 31, 2026" and furnishes the press release as Exhibit 99.1. The exhibit contains detailed financial metrics including revenue ($1.19M), gross profit ($0.50M), operating expenses ($3.38M), and net loss ($3.24M), along with strategic highlights including the company's recent IPO completion. This is a material disclosure affecting investor assessment of the registrant's financial performance and operational status.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 7.01
The filing discloses a scheduled earnings release announcement for PennantPark Floating Rate Capital Ltd.'s third fiscal quarter ended June 30, 2026, to be reported on August 10, 2026. The press release explicitly states the company "announced that it will report results for the third fiscal quarter ended June 30, 2026" and includes details of a conference call to discuss financial results. This is a material disclosure of quarterly earnings results, typical of Item 7.01 Regulation FD disclosures announcing earnings dates.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 7.01
The filing discloses a press release announcing PennantPark Investment Corporation's scheduled earnings release for the third fiscal quarter ended June 30, 2026, with results to be reported on August 10, 2026, and a conference call scheduled for August 11, 2026. Although this is technically an announcement of when earnings will be released rather than the earnings themselves, the core disclosure is the earnings announcement, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-06
Item 8.01
The press release announces that Brookfield Asset Management will host a second quarter 2026 results conference call on August 5, 2026, with results to be released that morning prior to 7:00 a.m. ET. This is a standard earnings announcement disclosing the timing and logistics for the release of quarterly financial results, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 7.01
The filing discloses an announcement of the Company's second quarter 2026 financial results to be released on August 6, 2026, with a conference call scheduled for August 7, 2026. The press release explicitly states "Morgan Stanley Direct Lending Fund Announces Second Quarter 2026 Earnings Release and Conference Call," which is a standard earnings announcement. This is material to investors as it provides notice of when quarterly financial results will be disclosed.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
Item 2.02
RxSight issued a press release on July 6, 2026 announcing preliminary unaudited second quarter 2026 financial results, including total company revenue of approximately $32–$34 million, LAL unit sales of 24,917 units, and cash position of approximately $209 million. The filing is disclosed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes updated 2026 full-year guidance ($140–$160 million revenue) and gross margin expectations, making it a material financial results announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
The 8-K discloses preliminary financial results and operating update for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The filing reports key financial metrics including cash position ($8.4M), elimination of convertible debt, 75% year-over-year decline in liabilities, and strong Vaunt growth metrics (199% YoY revenue growth, 250% ARR growth, 71% membership growth). This is a classic earnings release disclosure, albeit preliminary in nature.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-06
UMH Properties disclosed a second quarter 2026 operations update via press release (Exhibit 99.1) on July 2, 2026, reporting key financial and operational metrics including 10.3% increase in total rental income, 9.2% increase in home sales income, occupancy gains, and capital activities. Although filed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is an earnings/results update—preliminary quarterly operating results with specific revenue, occupancy, and sales figures that would materially inform investor assessment of the REIT's performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
The 8-K discloses Roadzen's financial results for Q4 and fiscal year ended March 31, 2026 via a press release attached as Exhibit 99.1. Item 2.02 explicitly states the company "issued a press release announcing its financial results for the fourth quarter and fiscal year ended March 31, 2026." The press release reports record quarterly revenue of $16.1 million (up 42% YoY), full-year revenue of $55.0 million (up 24%), and significant improvements in net loss (down 69%) and Adjusted EBITDA. This is a material earnings disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-06
The filing discloses Perfect Moment Ltd.'s fiscal Q4 and full year 2026 financial results via a press release dated June 29, 2026 (Exhibit 99.1), filed under Item 2.02 (Results of Operations and Financial Condition). The press release presents comprehensive financial highlights including revenue ($23.6M, +9.8% YoY), gross margin improvement (67.6% vs. 48.5%), and significant loss reduction ($7.1M net loss vs. $15.9M prior year), along with consolidated statements of operations and balance sheets. This is a standard earnings release disclosure material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-06
Item 2.02
AbbVie disclosed preliminary Q2 2026 financial results and updated full-year 2026 guidance under Item 2.02, including GAAP and adjusted non-GAAP diluted EPS with a $291 million acquired IPR&D and milestones expense impact. The filing provides revised adjusted diluted EPS guidance ranges for both Q2 2026 ($3.57–$3.61) and full-year 2026 ($13.91–$14.11), with supporting detail in Exhibit 99.1, which is characteristic of an earnings release disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 8.01
Ford's news release dated July 2, 2026 discloses second-quarter and first-half 2026 U.S. sales results, including total sales of 1,006,515 vehicles for the first half, market share data (12.3% June retail share), and detailed performance metrics across product lines (F-Series, Bronco, Explorer, Expedition, Maverick, etc.). This is a quarterly sales and operational performance disclosure typical of earnings releases, filed as Exhibit 99 and incorporated by reference under Item 8.01.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-02
EX-99.1
This is a press release announcing NIO's June and Q2 2026 delivery results, a key operational metric for an automotive manufacturer. The disclosure reports 40,597 vehicles delivered in June (up 62.9% YoY) and 107,658 in Q2 (up 49.4% YoY), along with cumulative deliveries of 1,188,715 units. While not a full earnings release with GAAP financials, delivery updates are material operational disclosures that directly inform investor assessment of the company's performance and market position, particularly for EV manufacturers where unit sales are a primary value driver.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-02
Item 2.02
EACO Corporation issued a press release on July 1, 2026 announcing third-quarter fiscal 2026 financial results, including net sales of $142.4 million (27.8% increase YoY), net income of $13.6 million (42.6% increase YoY), and basic EPS of $2.79 (43.1% increase YoY). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings releases.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-02
EX-99.1
This is a press release announcing XPENG's vehicle delivery results for June 2026 and Q2 2026 (103,295 units delivered in the quarter). The disclosure of quarterly delivery volumes is a key operational and financial metric for an automotive manufacturer that would materially affect investor assessment of the company's performance and market position. While not a traditional earnings release with full financial statements, delivery results are a material operational metric commonly disclosed by EV manufacturers as a proxy for near-term financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-02
Item 2.02
Lindsay Corporation issued a press release on July 2, 2026 announcing its third quarter fiscal 2026 results ended May 31, 2026, with detailed financial statements including revenues of $160.8 million, operating income of $18.5 million, and diluted EPS of $1.53. The disclosure includes segment results, balance sheet data, and cash flow information, which is the standard format for a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 2.02
The filing discloses an announcement of second quarter 2026 financial results to be released after market close on July 21, 2026, with a management conference call scheduled for July 22, 2026. The press release explicitly states that "Jeff Jackson, President and Chief Executive Officer, and Dan Weiss, Senior Executive Vice President and Chief Financial Officer, will review financial results for the second quarter of 2026." This is a standard earnings release announcement under Item 2.02, material to investors as it provides notice of upcoming quarterly financial disclosures.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-02
This 6-K furnishes a press release disclosing Embraer's second-quarter 2026 aircraft delivery results: 65 aircraft delivered (up 48% qoq and 7% yoy), with detailed segment breakdowns and updated full-year 2026 guidance. The disclosure of quarterly operational and financial metrics tied to revenue-generating deliveries is a material earnings-related announcement typical of an earnings release, even though it focuses on unit deliveries rather than GAAP net income.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 8.01
The filing announces the scheduled release and webcast of Bank of Marin Bancorp's Q2 2026 financial results for the quarter ended June 30, 2026, with the press release attached as Exhibit 99.1. The Item 8.01 disclosure explicitly states "Results will be released before the earnings call on Monday, July 27, 2026," and the exhibit confirms this is a formal earnings announcement. Quarterly financial results are material to investors and typically classified as earnings_release disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 2.02
National Beverage Corp. issued a press release on July 1, 2026 announcing financial results for fiscal year ended May 2, 2026, including net sales of $1.2 billion, gross profit of $437 million, and earnings per share of $1.96.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 2.02
Tesla disclosed Q2 2026 production (451,758 vehicles), deliveries (480,126 vehicles), and energy storage deployments (13.5 GWh) via press release attached as Exhibit 99.1 under Item 2.02. Although full financial results will be announced on July 22, 2026, this disclosure of operational metrics and production/delivery figures is a standard earnings-related announcement that would materially inform investors about the company's operational performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-07-02
Item 2.02
Lucid Group issued a press release announcing Q2 2026 production and delivery totals of 4,774 vehicles produced and 3,953 delivered.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 7.01
The filing discloses the Company's plan to issue its earnings release for the quarter ended June 30, 2026, on July 20, 2026, and host a conference call on July 21, 2026 with Chairman and CEO John W. Bordelon, President Darren E. Guidry, and CFO David T. Kirkley to discuss second quarter results. Although this is technically an announcement of a future earnings release rather than the release itself, the substance is a disclosure of material quarterly financial results, which is a standard earnings_release event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
The filing discloses an announcement that Horizon Bancorp will release its second quarter 2026 financial results after market close on July 22, 2026, with a management conference call scheduled for July 23, 2026. The press release (Exhibit 99.1) explicitly states "Horizon Bancorp, Inc. Announces Conference Call to Review Second Quarter Results," which is a standard earnings release notification. This is a material disclosure of quarterly financial results typical of Item 2.02 filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-01
Item 2.02
Biogen discloses preliminary unaudited financial results for Q2 2026 and provides guidance for Q3 2026, including specific charges ($164M for Q2, $290-320M for Q3) and their impact on GAAP and non-GAAP earnings per share ($0.95 and $1.75-1.95 respectively). While the disclosure focuses on acquired in-process R&D and milestone expenses rather than comprehensive earnings, it constitutes a material financial results disclosure under Item 2.02 that would affect investor assessment of quarterly performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-01
EX-99.4
British American Tobacco disclosed H1 2026 financial results and full-year 2026 guidance, including detailed performance metrics across business segments (U.S., AME, APMEA) and product categories, with mid-teens revenue growth expectations for H1 and full-year 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
MSC Industrial Direct issued a press release on July 1, 2026 announcing financial results for fiscal 2026 third quarter ended May 30, 2026. The disclosure includes detailed financial highlights (net sales of $1,047.1M up 7.8% YoY, diluted EPS of $1.44 vs. $1.02 prior year), condensed consolidated financial statements, and forward guidance for Q4 and full-year fiscal 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
CION Investment Corporation announced the scheduling of its second quarter 2026 earnings release and conference call for August 6, 2026 at 11:00 a.m. ET, providing investors with notice of when financial results for the quarter ended June 30, 2026 will be disclosed.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-07-01
EX-99.1
This exhibit is a press release announcing Biophytis's provisional, unaudited financial results for fiscal year 2025, including net loss of €7.8 million, cash position of €190 thousand, and a going-concern disclosure. While the results are presented as "provisional" pending audit completion, the disclosure of annual financial results, material uncertainty regarding going concern, and strategic updates constitute a material earnings announcement that would affect a reasonable investor's assessment of the company's financial condition and viability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
This is a clear earnings release disclosing financial results for fiscal year ended March 31, 2025. The company issued a press release on June 30, 2026, reporting a net loss of $4.9M on revenues of $9.3M, with detailed consolidated balance sheets and statements of operations attached as Exhibit 99.1. The disclosure includes material financial metrics (gross margin decline of 24 percentage points, operating loss of $2.3M vs. prior year operating income of $737K) and forward-looking guidance, making it material to investors' assessment of the registrant's financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
Blue Owl Capital Corporation issued a press release announcing the scheduled release of its financial results for Q2 2026 (ending June 30, 2026) on August 5, 2026, along with a conference call on August 6, 2026. While this is technically an announcement of a future earnings release rather than the release of actual results, Item 2.02 disclosures of earnings announcements and scheduled earnings calls are classified as earnings_release events. The filing includes the full press release as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
The filing discloses a scheduled announcement of financial results for Q2 2026 (ended June 30, 2026) to be released on August 5, 2026, with an accompanying earnings webcast on August 6, 2026. Although the actual results are not yet disclosed in this 8-K, the press release announces the timing and logistics of the earnings release and conference call, which is the standard form of earnings_release disclosure under Item 2.02. This is material to investors as it relates to the company's quarterly financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
The filing discloses Greenbrier's third fiscal quarter financial results for the period ended May 31, 2026, including revenue of $576.5M, net earnings of $18.9M ($0.60 diluted EPS), and EBITDA of $69.1M. The earnings release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard Item for quarterly earnings disclosures. Material metrics such as gross margin improvement (230 basis points sequentially), lease fleet growth to 20,600 units, and updated fiscal 2026 guidance are disclosed.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-01
Item 2.02
Franklin Covey disclosed its third quarter fiscal 2026 financial results on July 1, 2026, reporting consolidated revenue of $67.8 million, net income of $3.1 million (versus a prior-year loss), Adjusted EBITDA of $8.3 million with 14% growth, and revised full-year fiscal 2026 guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
This is a clear earnings release disclosing Culp Inc.'s fourth quarter and full fiscal year 2026 financial results. The Item 2.02 filing explicitly states "Culp, Inc. issued a news release to announce financial results for its fourth quarter and fiscal year ended May 3, 2026," with the full press release attached as Exhibit 99.1. The disclosure includes consolidated net sales, gross profit, operating loss, net loss per share, and segment performance metrics, along with forward guidance for fiscal 2027.
View raw filing on EDGAR →
6-K
Earnings release
confidence 25%
filed 2026-07-01
EX-99.1
This is a clinical trial results announcement for Namodenoson in a Phase 2a pancreatic cancer study. While it discloses positive safety and survival outcomes, it is not a financial earnings release (no quarterly or annual financial results). The disclosure is material to investors as it reports clinical progress on a key pipeline asset, but the event_type taxonomy does not contain a specific category for clinical trial results or product development milestones. This is an operational/strategic disclosure about drug development progress that does not fit neatly into the provided categories.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
This is a clear earnings release disclosing Bassett Furniture's second quarter financial results for the fiscal year ending November 28, 2026. The Item 2.02 filing includes a news release (Exhibit 99.1) announcing Q2 results with detailed financial statements, segment information, and management commentary. The disclosure covers revenues ($83.8M), operating income ($2.2M), gross margin (56.5%), diluted EPS ($0.24), and cash flow metrics, making it a standard quarterly earnings announcement material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-01
EX-99.1
This exhibit is a press release announcing Locafy's financial results for the nine-month period ended March 31, 2026. The document explicitly states "Locafy Reports 31% Revenue Growth for the First Nine Months of Fiscal 2026" and provides detailed financial highlights including subscription revenue growth of 36%, operating expense reductions of 13%, and net loss improvement of 36%. The release includes consolidated financial statements (profit/loss, balance sheet, and cash flows) and management commentary from the CEO. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-01
Item 2.02
Athene disclosed preliminary estimates of alternative net investment income of $350 million pre-tax with a 9% annualized return for Q2 2026 as a Regulation FD disclosure prior to Apollo's full earnings release on August 4, 2026. This constitutes an early release of material quarterly financial results and key performance metrics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
General Mills issued a press release on July 1, 2026 reporting financial results for its quarter and fiscal year ended May 31, 2026. The disclosure includes detailed quarterly and full-year results covering net sales, operating profit, diluted EPS, segment performance, and forward guidance. This is a standard earnings release disclosing quarterly and annual financial results, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
FactSet disclosed its third quarter fiscal 2026 financial results via press release on July 1, 2026, reporting GAAP revenues of $622.9 million (up 6.4% YoY), organic ASV growth of 7.1%, and adjusted diluted EPS of $4.53 (up 6.1% YoY). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
UniFirst issued a press release on July 1, 2026 announcing financial results for the third quarter of fiscal 2026 ended May 30, 2026. The disclosure includes consolidated revenues of $634.4 million, operating income of $23.0 million, net income of $19.9 million, and diluted EPS of $1.09, along with detailed segment reporting and balance sheet information. This is a standard quarterly earnings release attached as Exhibit 99 to the 8-K filing under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-01
Item 2.02
Apollo Global Management disclosed preliminary estimates of alternative net investment income of $350 million pre-tax with a 9% annualized return for Q2 2026 via Regulation FD disclosure, prior to its full earnings release scheduled for August 4, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-06-30
Item 2.02
Constellation Brands disclosed Q1 FY2027 financial results (ended May 31, 2026) with reported EPS of $3.79 and comparable EPS of $3.43, net sales of $2,433 million, and operating income of $845 million across Beer and Wine and Spirits segments, along with updated fiscal 2027 guidance and a quarterly cash dividend of $1.03 per share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-06-30
Item 2.02
This is a clear earnings release disclosing NIKE's fiscal 2026 fourth quarter and full-year financial results. The press release, furnished as Exhibit 99.1, reports full-year revenues of $46.4 billion (flat reported, down 2% currency-neutral), net income of $3.1 billion (down 3%), and diluted EPS of $2.10 (down 3%), along with detailed income statements, balance sheets, and divisional revenue breakdowns. This is a material disclosure affecting investor assessment of the company's financial performance and position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-30
Item 2.02
Progress Software issued a press release on June 30, 2026 announcing financial results for the fiscal second quarter ended May 31, 2026, reporting revenue of $253 million (7% YoY growth), diluted EPS of $0.50 (28% increase), and updated full-year 2026 guidance with increased revenue and EPS expectations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-30
Item 7.01
The disclosure announces Labcorp's intention to release second quarter 2026 financial results on July 30, 2026, with a conference call and webcast to discuss results. The press release explicitly states "Labcorp to Announce Second Quarter Financial Results" and references the earnings press release and accompanying financial information that will be posted. This is a standard earnings announcement disclosure, material to investors as it provides notice of when quarterly financial results will be publicly disclosed.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-06-30
EX-99.1
This is a clinical trial data announcement press release disclosing interim 12-month results from the Phase 1b/2 ABATE trial of ACI-24. While not traditional financial earnings, the disclosure of clinical trial progress, safety data, and dose-response results for a lead therapeutic candidate is material to investors in a clinical-stage biopharmaceutical company. The announcement also references a $12 million milestone payment from Takeda triggered by dosing in Cohort AD4, which is a material financial event. The press release format and disclosure of interim trial results align with how clinical-stage biotech companies communicate material operational and financial developments to investors.
View raw filing on EDGAR →